ログイン

RLE

RLE
52問 • 2年前
  • Kharylle Salvador
  • 通報

    問題一覧

  • 1

    The level of circulating blood glucose as measured by glucometer analysis of a fingerstick sample

    CBG

  • 2

    CBG helps to determine or monitor blood glucose levels of clients at risk for

    hypoglycemia or hyperglycaemia

  • 3

    CBG helps to evaluate the effectiveness of

    Insulin administration

  • 4

    FASTING

    less than 100

  • 5

    Before meal

    70-130

  • 6

    After meal (1-2 hours)

    Less than 180

  • 7

    Before exercise

    If taking insulin atleast 100

  • 8

    Bedtime

    100-140

  • 9

    This side avoids the nerve endings and calloused areas at the fingertips

    Lateral aspect or side of the finger

  • 10

    May be used in client in shock or edematous fingers

    Earlobe

  • 11

    most common site for neonates and infants

    Outer aspect of the heel

  • 12

    Other sites

    Arms,legs, abdomen

  • 13

    What to do before obtaining cbg on infants

    Place a warm clothe on the infant's heel to increase blood flow in the area

  • 14

    What to do before obtaining cbg on children

    Allow child to choose puncture site

  • 15

    What to do before obtaining cbg on elders

    Wrap a warm washcloth 3-5 minutes

  • 16

    Short acting start working how many minutes after injection

    30-60 minute's

  • 17

    Strongest effect time on rapid acting

    30-90 minutes

  • 18

    Rapid acting insulins

    Lispro,Aspart,Glusinine

  • 19

    Short acting keeps working until

    3-6 hours

  • 20

    Intermediate-acting

    NPH,NPL

  • 21

    Slower absorption and with no pronounced peak

    Long acting

  • 22

    Long acting insulins

    Glargine,determir

  • 23

    Insulin syringes

    U-30,U-50,U-100

  • 24

    Where to give insulines?

    Under arm,buttocks,thigh,abdomen

  • 25

    Move how many inch from the last olace given

    1

  • 26

    It can affect rate of insulin absorption

    Excersise

  • 27

    Degree angles of insulin administrations

    45 and 90

  • 28

    Properway of administration of insulin

    CRPFIR

  • 29

    It delivers both basal and bolus doses of insulin

    Pump

  • 30

    Example of areas of flexion

    Antecubital fossa

  • 31

    It is the introduction of whole blood or blood components into venous circulation

    Blood transfusion

  • 32

    Human blood is commonly classified into 4 main groups namely

    A,B,AB,O

  • 33

    Proteins on the surface of an individual's rbc that are unique for each person

    Blood antigens

  • 34

    Antigens promotote ______ or clumping of blood cells, also known as ____.

    Agglutination; agglutinogens

  • 35

    Specific antibodies formed in the plasma

    Agglutinins

  • 36

    Done to determine the ABO blood group and RH facto status

    Blood typing

  • 37

    Done to identify possible interactions of minor antigens with their corresponding antibodies

    Crossmatching

  • 38

    RA for voluntary blood donation

    RA 7719

  • 39

    Selection of blood donors

    5

  • 40

    Weeks for Red Cross

    6 weeks

  • 41

    Weeks for WHO

    9 weeks

  • 42

    Not commonly used except for extreme cases of acute hemorrhage

    Whole blood

  • 43

    Replaces blood volume and all blood products

    Whole blood

  • 44

    Used for blood replacement following planned elective surgery

    Autologous RBCs

  • 45

    Replaces platelets in clients with bleeding disorders

    Platelets l

  • 46

    Use to increase the oxygen-carrying capacity of blood in anemias, surgery and disorders with slow bleeding

    Packed RBCs

  • 47

    Used for clients with clotting factors deficiencies

    Clotting factors and cryoprecipitate

  • 48

    Storage temperature for whole blood and red cells

    +2,+6

  • 49

    Storage temperature for fresh frozen plasma

    -20 degrees Celsius or lower

  • 50

    Storage temperature for platelets

    +20 and +24

  • 51

    Storage temperature for cryoprecipitate

    below -30

  • 52

    Blood volume expander

    Albumin and plasma protein fraction

  • Raynaud's Phenomenon

    Raynaud's Phenomenon

    Kharylle Salvador · 8問 · 2年前

    Raynaud's Phenomenon

    Raynaud's Phenomenon

    8問 • 2年前
    Kharylle Salvador

    Varicose Veins

    Varicose Veins

    Kharylle Salvador · 5問 · 2年前

    Varicose Veins

    Varicose Veins

    5問 • 2年前
    Kharylle Salvador

    ETHICO-LEGAL

    ETHICO-LEGAL

    Kharylle Salvador · 54問 · 2年前

    ETHICO-LEGAL

    ETHICO-LEGAL

    54問 • 2年前
    Kharylle Salvador

    COPAR RLE

    COPAR RLE

    Kharylle Salvador · 25問 · 2年前

    COPAR RLE

    COPAR RLE

    25問 • 2年前
    Kharylle Salvador

    Chemotherapy

    Chemotherapy

    Kharylle Salvador · 8問 · 2年前

    Chemotherapy

    Chemotherapy

    8問 • 2年前
    Kharylle Salvador

    Blood Disorders (ANEMIA)

    Blood Disorders (ANEMIA)

    Kharylle Salvador · 11問 · 2年前

    Blood Disorders (ANEMIA)

    Blood Disorders (ANEMIA)

    11問 • 2年前
    Kharylle Salvador

    Research

    Research

    Kharylle Salvador · 20問 · 2年前

    Research

    Research

    20問 • 2年前
    Kharylle Salvador

    CELLULAR ABERRATION

    CELLULAR ABERRATION

    Kharylle Salvador · 63問 · 2年前

    CELLULAR ABERRATION

    CELLULAR ABERRATION

    63問 • 2年前
    Kharylle Salvador

    Immune System

    Immune System

    Kharylle Salvador · 19問 · 2年前

    Immune System

    Immune System

    19問 • 2年前
    Kharylle Salvador

    FLUIDS AND ELECTROLYTES

    FLUIDS AND ELECTROLYTES

    Kharylle Salvador · 32問 · 2年前

    FLUIDS AND ELECTROLYTES

    FLUIDS AND ELECTROLYTES

    32問 • 2年前
    Kharylle Salvador

    Therapeutic Communication

    Therapeutic Communication

    Kharylle Salvador · 16問 · 2年前

    Therapeutic Communication

    Therapeutic Communication

    16問 • 2年前
    Kharylle Salvador

    PSYCH

    PSYCH

    Kharylle Salvador · 12問 · 2年前

    PSYCH

    PSYCH

    12問 • 2年前
    Kharylle Salvador

    MS RLE

    MS RLE

    Kharylle Salvador · 46問 · 1年前

    MS RLE

    MS RLE

    46問 • 1年前
    Kharylle Salvador

    問題一覧

  • 1

    The level of circulating blood glucose as measured by glucometer analysis of a fingerstick sample

    CBG

  • 2

    CBG helps to determine or monitor blood glucose levels of clients at risk for

    hypoglycemia or hyperglycaemia

  • 3

    CBG helps to evaluate the effectiveness of

    Insulin administration

  • 4

    FASTING

    less than 100

  • 5

    Before meal

    70-130

  • 6

    After meal (1-2 hours)

    Less than 180

  • 7

    Before exercise

    If taking insulin atleast 100

  • 8

    Bedtime

    100-140

  • 9

    This side avoids the nerve endings and calloused areas at the fingertips

    Lateral aspect or side of the finger

  • 10

    May be used in client in shock or edematous fingers

    Earlobe

  • 11

    most common site for neonates and infants

    Outer aspect of the heel

  • 12

    Other sites

    Arms,legs, abdomen

  • 13

    What to do before obtaining cbg on infants

    Place a warm clothe on the infant's heel to increase blood flow in the area

  • 14

    What to do before obtaining cbg on children

    Allow child to choose puncture site

  • 15

    What to do before obtaining cbg on elders

    Wrap a warm washcloth 3-5 minutes

  • 16

    Short acting start working how many minutes after injection

    30-60 minute's

  • 17

    Strongest effect time on rapid acting

    30-90 minutes

  • 18

    Rapid acting insulins

    Lispro,Aspart,Glusinine

  • 19

    Short acting keeps working until

    3-6 hours

  • 20

    Intermediate-acting

    NPH,NPL

  • 21

    Slower absorption and with no pronounced peak

    Long acting

  • 22

    Long acting insulins

    Glargine,determir

  • 23

    Insulin syringes

    U-30,U-50,U-100

  • 24

    Where to give insulines?

    Under arm,buttocks,thigh,abdomen

  • 25

    Move how many inch from the last olace given

    1

  • 26

    It can affect rate of insulin absorption

    Excersise

  • 27

    Degree angles of insulin administrations

    45 and 90

  • 28

    Properway of administration of insulin

    CRPFIR

  • 29

    It delivers both basal and bolus doses of insulin

    Pump

  • 30

    Example of areas of flexion

    Antecubital fossa

  • 31

    It is the introduction of whole blood or blood components into venous circulation

    Blood transfusion

  • 32

    Human blood is commonly classified into 4 main groups namely

    A,B,AB,O

  • 33

    Proteins on the surface of an individual's rbc that are unique for each person

    Blood antigens

  • 34

    Antigens promotote ______ or clumping of blood cells, also known as ____.

    Agglutination; agglutinogens

  • 35

    Specific antibodies formed in the plasma

    Agglutinins

  • 36

    Done to determine the ABO blood group and RH facto status

    Blood typing

  • 37

    Done to identify possible interactions of minor antigens with their corresponding antibodies

    Crossmatching

  • 38

    RA for voluntary blood donation

    RA 7719

  • 39

    Selection of blood donors

    5

  • 40

    Weeks for Red Cross

    6 weeks

  • 41

    Weeks for WHO

    9 weeks

  • 42

    Not commonly used except for extreme cases of acute hemorrhage

    Whole blood

  • 43

    Replaces blood volume and all blood products

    Whole blood

  • 44

    Used for blood replacement following planned elective surgery

    Autologous RBCs

  • 45

    Replaces platelets in clients with bleeding disorders

    Platelets l

  • 46

    Use to increase the oxygen-carrying capacity of blood in anemias, surgery and disorders with slow bleeding

    Packed RBCs

  • 47

    Used for clients with clotting factors deficiencies

    Clotting factors and cryoprecipitate

  • 48

    Storage temperature for whole blood and red cells

    +2,+6

  • 49

    Storage temperature for fresh frozen plasma

    -20 degrees Celsius or lower

  • 50

    Storage temperature for platelets

    +20 and +24

  • 51

    Storage temperature for cryoprecipitate

    below -30

  • 52

    Blood volume expander

    Albumin and plasma protein fraction